The prevalence of obesity in India was lower than in other countries but now it's increasing, Rachel Batterham, senior vice ...

Research tells us that eating enough protein and staying physically active can be helpful in reducing the amount of non-fat ...

Lisa Miller interviewed more than two dozen people about the effects weight-loss drugs have had on their romantic ...

More and more people are taking weight loss injectables like Wegovy and Mounjaro — and pharmacy experts are worried that not ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

Wall Street is bullish on Viking, but the company still has a lot to prove. Viking has a number of different clinical studies ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...